a public good project by the
Synthesis
Company
of California

© 2026

David J. Moliterno | doi.page

0 works0 citations0 h-index

David J. Moliterno

University of Kentucky(US)

Publications by Year

Research Areas

Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management

Most-Cited Works

→ Ticagrelor with or without Aspirin in High-Risk Patients after PCI(2019)970 cited
→ Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes(2011)751 cited
→ Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study(2013)611 cited
→ Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents(2016)537 cited
→ Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention(2019)523 cited
→ ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use(2008)383 cited

→ Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial(2016)

325 cited

→ Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study(2009)296 cited

→ Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction(2001)290 cited

→ Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention(2021)285 cited